查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566973

客自订抗体服务市场：按服务、按类型、按来源、按应用、按最终用户：2024-2033 年全球机会分析和行业预测

Custom Antibody Services Market By Service , By Type By Source By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 233 Pages | 商品交期: 2-3个工作天内

价格
简介目录

自订抗体服务市场

2023年客製自订抗体服务市值为6亿美元，预计2024年至2033年复合年增长率为8.7%，到2033年达到14亿美元。

透过我们的客自订抗体服务，我们根据使用者的要求创建抗体。抗体专为诊断、研究和治疗目的而量身定制。使用自订抗体服务的一个主要好处是能够实现抗体对其抗原的特异性，从而获得可靠的实验结果。此外，对抗体进行各种修改的灵活性使得自订抗体服务对客户有吸引力。

用于标靶治疗的个人化医疗的日益普及正在增加自订抗体服务在医疗领域的采用。此外，製药和生技公司加强研发活动的支出迅速增加也是市场成长的主要动力。重组技术和新型抗体趋势预计将重新定义客自订抗体服务市场的未来。人工智慧和机器学习演算法有望支持抗体设计和开发新一代抗体，包括单域抗体、双特异性抗体和抗体片段。

然而，抗体生产成本高且开发时间长阻碍了客製自订抗体服务市场的成长。此外，为抗体批准建立的品管措施和验证流程非常严格且耗时。有效遵守此类标准会减缓市场成长。相较之下，由于药物开发和研发投资的自订，客製化抗体服务市场预计将发现一些利润丰厚的成长机会。根据全球资料和商业智慧平台 Statista 的数据，预计 2022 年美国在药品上的支出将达到 6,030 亿美元。此外，美国製药公司将约 21% 的收益用于研发活动。这些支出显示自订抗体服务市场前景光明。

按部门审查

客自订抗体服务市场分为服务、类型、来源、应用、最终用户和区域。依服务划分，市场分为抗体开拓、抗体生产/精製及抗体分割/标记。依类型分为单株抗体、多株抗体、重组抗体等。依来源分为小鼠、兔、其他。依应用分类，可分为肿瘤学、感染疾病、神经学、免疫学、心血管疾病等。依最终用户划分，可分为製药/生技公司、学术/研究机构等。从区域来看，分析包括北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

从服务来看，抗体开发领域在 2023 年占据市场主导地位。

从类型来看，单株抗体领域是2023年市场的主要股东。

消息人士透露，2023年兔子细分市场将占据较高份额。

从应用来看，2023年感染疾病细分市场占较高份额。

从最终用户来看，製药和生技公司在 2023 年占据了较高的市场。

按地区划分，北美地区 2023 年收益最高。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 扩大公司简介列表
  • 历史市场资料
  • 主要参与企业的详细资料（Excel格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章客自订抗体服务市场：依服务分类

  • 市场概况
  • 抗体开发
  • 抗体生产和精製
  • 抗体分割和标记

第五章自订抗体服务市场：依类型

  • 市场概况
  • 单株抗体
  • 多株抗体
  • 重组抗体
  • 其他的

第六章客自订抗体服务市场：依来源分类

  • 市场概况
  • 老鼠
  • 兔子
  • 其他的

第七章客自订抗体服务市场：依应用分类

  • 市场概况
  • 肿瘤学
  • 感染疾病
  • 神经病学
  • 免疫学
  • 心血管疾病
  • 其他的

第八章客自订抗体服务市场：依最终用户分类

  • 市场概况
  • 製药和生物技术公司
  • 学术/研究机构
  • 其他的

第九章客自订抗体服务市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国自订抗体服务市场
    • 加拿大客自订抗体服务市场
    • 墨西哥客自订抗体服务市场
  • 欧洲
    • 主要市场趋势和机会
    • 德国客自订抗体服务市场
    • 法国自订抗体服务市场
    • 英国自订抗体服务市场
    • 义大利客自订抗体服务市场
    • 西班牙客自订抗体服务市场
    • 其他欧洲自订抗体服务市场
  • 亚太地区
    • 主要市场趋势和机会
    • 日本客自订抗体服务市场
    • 中国客自订抗体服务市场
    • 印度客自订抗体服务市场
    • 澳洲抗体服务市场
    • 韩国自订抗体服务市场
    • 其他亚太地区自订抗体服务市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西客自订抗体服务市场
    • 沙乌地阿拉伯客自订抗体服务市场
    • 南非客自订抗体服务市场
    • 其他拉丁美洲/中东/非洲客自订抗体服务市场

第10章竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第十一章 公司简介

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Sino Biological, Inc.
  • Bio-Rad Laboratories, Inc
  • Kaneka Eurogentec SA
  • YenZym Antibodies, LLC.
  • OriGene Technologies, Inc.
  • Laboratory Corporation of America Holdings.
  • GenScript
简介目录
Product Code: A324397

Custom Antibody Services Market

The custom antibody services market was valued at $0.6 billion in 2023 and is projected to reach $1.4 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033.

Custom antibody services involve producing distinguished antibodies as per user requirements. The antibodies are specifically tailored for diagnostic, research, and therapeutic purposes. A key benefit of utilizing custom antibody services is the attainability of specificity in antibodies against antigens, resulting in improved & reliable experimental results. In addition, the flexibility of integrating different modifications into the antibodies attracts clients to benefit from the custom antibody services.

Increase in the popularity of personalized medicine for targeted therapies is rising the adoption of custom antibody services in the healthcare field. In addition, with surging expenditure in the pharmaceutical and biotech sectors for the strengthening of their R&D activities, the growth of the market is being driven considerably. The future of the custom antibody services market is anticipated to be redefined by recombinant technology and novel antibody trends. AI and ML algorithm are poised to assist in the designing of antibodies and develop next-generational antibodies such as single domain antibodies, bispecific antibodies, and antibody fragments.

However, the high cost of antibody production and extended development time hamper the growth of the custom antibody services market. In addition, the quality control measures and validation processes established for the approval of antibodies are highly rigorous and time-consuming. Efficient compliance with such standards delays the growth of the market. Contrarily, with rising investments on drug development and R&D, the custom antibody services market is anticipated to witness several lucrative growth opportunities. According to Statista, a global data and business intelligence platform, the U.S. spent an estimated amount of $603 billion on medicine in 2022. Furthermore, pharma companies in the U.S. spend approximately 21% of their revenue on R&D activities. Such expenditures indicate a promising future for the custom antibody services market.

Segment Review

The custom antibody services market is segmented into service, type, source, application, end user, and region. On the basis of service, the market is divided into antibody development, antibody production & purification, and antibody fragmentation & labeling. As per type, it is classified into monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and others. Depending on source, it is categorized into mice, rabbit, and others. According to application, it is divided into oncology, infectious diseases, neurology, immunology, cardiovascular diseases, and others. By end user, it is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of service, the antibody development segment dominated the market in 2023.

As per type, the monoclonal antibodies segment was the major shareholder of the market in 2023.

Depending on source, the rabbit segment held a high share in the market in 2023.

According to application, the infectious diseases segment accounted for a high share in the market in 2023.

By end user, the pharmaceutical & biotechnology companies segment acquired a high stake in the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players of the global custom antibody services market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., Sino Biological, Inc., Bio-Rad Laboratories, Inc, Kaneka Eurogentec S.A., YenZym Antibodies, LLC., OriGene Technologies, Inc., Laboratory Corporation of America Holdings., and GenScript. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Service

  • Antibody Development
  • Antibody Production and Purification
  • Antibody Fragmentation and Labeling

By Type

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies
  • Others

By Source

  • Mice
  • Rabbit
  • Others

By Application

  • Oncology
  • Infectious Diseases
  • Neurology
  • Immunology
  • Cardiovascular Diseases
  • Others

By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Sino Biological, Inc.
    • Bio-Rad Laboratories, Inc
    • Kaneka Eurogentec S.A.
    • YenZym Antibodies, LLC.
    • OriGene Technologies, Inc.
    • Laboratory Corporation of America Holdings.
    • GenScript

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: CUSTOM ANTIBODY SERVICES MARKET, BY SERVICE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Service
  • 4.2. Antibody Development
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Antibody Production And Purification
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Antibody Fragmentation And Labeling
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: CUSTOM ANTIBODY SERVICES MARKET, BY TYPE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Type
  • 5.2. Monoclonal Antibodies
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Polyclonal Antibodies
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Recombinant Antibodies
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Others
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: CUSTOM ANTIBODY SERVICES MARKET, BY SOURCE

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Source
  • 6.2. Mice
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Rabbit
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: CUSTOM ANTIBODY SERVICES MARKET, BY APPLICATION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Application
  • 7.2. Oncology
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Infectious Diseases
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Neurology
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country
  • 7.5. Immunology
    • 7.5.1. Key Market Trends, Growth Factors and Opportunities
    • 7.5.2. Market Size and Forecast, By Region
    • 7.5.3. Market Share Analysis, By Country
  • 7.6. Cardiovascular Diseases
    • 7.6.1. Key Market Trends, Growth Factors and Opportunities
    • 7.6.2. Market Size and Forecast, By Region
    • 7.6.3. Market Share Analysis, By Country
  • 7.7. Others
    • 7.7.1. Key Market Trends, Growth Factors and Opportunities
    • 7.7.2. Market Size and Forecast, By Region
    • 7.7.3. Market Share Analysis, By Country

CHAPTER 8: CUSTOM ANTIBODY SERVICES MARKET, BY END USER

  • 8.1. Market Overview
    • 8.1.1 Market Size and Forecast, By End User
  • 8.2. Pharmaceutical And Biotechnology Companies
    • 8.2.1. Key Market Trends, Growth Factors and Opportunities
    • 8.2.2. Market Size and Forecast, By Region
    • 8.2.3. Market Share Analysis, By Country
  • 8.3. Academic And Research Institutes
    • 8.3.1. Key Market Trends, Growth Factors and Opportunities
    • 8.3.2. Market Size and Forecast, By Region
    • 8.3.3. Market Share Analysis, By Country
  • 8.4. Others
    • 8.4.1. Key Market Trends, Growth Factors and Opportunities
    • 8.4.2. Market Size and Forecast, By Region
    • 8.4.3. Market Share Analysis, By Country

CHAPTER 9: CUSTOM ANTIBODY SERVICES MARKET, BY REGION

  • 9.1. Market Overview
    • 9.1.1 Market Size and Forecast, By Region
  • 9.2. North America
    • 9.2.1. Key Market Trends and Opportunities
    • 9.2.2. Market Size and Forecast, By Service
    • 9.2.3. Market Size and Forecast, By Type
    • 9.2.4. Market Size and Forecast, By Source
    • 9.2.5. Market Size and Forecast, By Application
    • 9.2.6. Market Size and Forecast, By End User
    • 9.2.7. Market Size and Forecast, By Country
    • 9.2.8. U.S. Custom Antibody Services Market
      • 9.2.8.1. Market Size and Forecast, By Service
      • 9.2.8.2. Market Size and Forecast, By Type
      • 9.2.8.3. Market Size and Forecast, By Source
      • 9.2.8.4. Market Size and Forecast, By Application
      • 9.2.8.5. Market Size and Forecast, By End User
    • 9.2.9. Canada Custom Antibody Services Market
      • 9.2.9.1. Market Size and Forecast, By Service
      • 9.2.9.2. Market Size and Forecast, By Type
      • 9.2.9.3. Market Size and Forecast, By Source
      • 9.2.9.4. Market Size and Forecast, By Application
      • 9.2.9.5. Market Size and Forecast, By End User
    • 9.2.10. Mexico Custom Antibody Services Market
      • 9.2.10.1. Market Size and Forecast, By Service
      • 9.2.10.2. Market Size and Forecast, By Type
      • 9.2.10.3. Market Size and Forecast, By Source
      • 9.2.10.4. Market Size and Forecast, By Application
      • 9.2.10.5. Market Size and Forecast, By End User
  • 9.3. Europe
    • 9.3.1. Key Market Trends and Opportunities
    • 9.3.2. Market Size and Forecast, By Service
    • 9.3.3. Market Size and Forecast, By Type
    • 9.3.4. Market Size and Forecast, By Source
    • 9.3.5. Market Size and Forecast, By Application
    • 9.3.6. Market Size and Forecast, By End User
    • 9.3.7. Market Size and Forecast, By Country
    • 9.3.8. Germany Custom Antibody Services Market
      • 9.3.8.1. Market Size and Forecast, By Service
      • 9.3.8.2. Market Size and Forecast, By Type
      • 9.3.8.3. Market Size and Forecast, By Source
      • 9.3.8.4. Market Size and Forecast, By Application
      • 9.3.8.5. Market Size and Forecast, By End User
    • 9.3.9. France Custom Antibody Services Market
      • 9.3.9.1. Market Size and Forecast, By Service
      • 9.3.9.2. Market Size and Forecast, By Type
      • 9.3.9.3. Market Size and Forecast, By Source
      • 9.3.9.4. Market Size and Forecast, By Application
      • 9.3.9.5. Market Size and Forecast, By End User
    • 9.3.10. UK Custom Antibody Services Market
      • 9.3.10.1. Market Size and Forecast, By Service
      • 9.3.10.2. Market Size and Forecast, By Type
      • 9.3.10.3. Market Size and Forecast, By Source
      • 9.3.10.4. Market Size and Forecast, By Application
      • 9.3.10.5. Market Size and Forecast, By End User
    • 9.3.11. Italy Custom Antibody Services Market
      • 9.3.11.1. Market Size and Forecast, By Service
      • 9.3.11.2. Market Size and Forecast, By Type
      • 9.3.11.3. Market Size and Forecast, By Source
      • 9.3.11.4. Market Size and Forecast, By Application
      • 9.3.11.5. Market Size and Forecast, By End User
    • 9.3.12. Spain Custom Antibody Services Market
      • 9.3.12.1. Market Size and Forecast, By Service
      • 9.3.12.2. Market Size and Forecast, By Type
      • 9.3.12.3. Market Size and Forecast, By Source
      • 9.3.12.4. Market Size and Forecast, By Application
      • 9.3.12.5. Market Size and Forecast, By End User
    • 9.3.13. Rest of Europe Custom Antibody Services Market
      • 9.3.13.1. Market Size and Forecast, By Service
      • 9.3.13.2. Market Size and Forecast, By Type
      • 9.3.13.3. Market Size and Forecast, By Source
      • 9.3.13.4. Market Size and Forecast, By Application
      • 9.3.13.5. Market Size and Forecast, By End User
  • 9.4. Asia-Pacific
    • 9.4.1. Key Market Trends and Opportunities
    • 9.4.2. Market Size and Forecast, By Service
    • 9.4.3. Market Size and Forecast, By Type
    • 9.4.4. Market Size and Forecast, By Source
    • 9.4.5. Market Size and Forecast, By Application
    • 9.4.6. Market Size and Forecast, By End User
    • 9.4.7. Market Size and Forecast, By Country
    • 9.4.8. Japan Custom Antibody Services Market
      • 9.4.8.1. Market Size and Forecast, By Service
      • 9.4.8.2. Market Size and Forecast, By Type
      • 9.4.8.3. Market Size and Forecast, By Source
      • 9.4.8.4. Market Size and Forecast, By Application
      • 9.4.8.5. Market Size and Forecast, By End User
    • 9.4.9. China Custom Antibody Services Market
      • 9.4.9.1. Market Size and Forecast, By Service
      • 9.4.9.2. Market Size and Forecast, By Type
      • 9.4.9.3. Market Size and Forecast, By Source
      • 9.4.9.4. Market Size and Forecast, By Application
      • 9.4.9.5. Market Size and Forecast, By End User
    • 9.4.10. India Custom Antibody Services Market
      • 9.4.10.1. Market Size and Forecast, By Service
      • 9.4.10.2. Market Size and Forecast, By Type
      • 9.4.10.3. Market Size and Forecast, By Source
      • 9.4.10.4. Market Size and Forecast, By Application
      • 9.4.10.5. Market Size and Forecast, By End User
    • 9.4.11. Australia Custom Antibody Services Market
      • 9.4.11.1. Market Size and Forecast, By Service
      • 9.4.11.2. Market Size and Forecast, By Type
      • 9.4.11.3. Market Size and Forecast, By Source
      • 9.4.11.4. Market Size and Forecast, By Application
      • 9.4.11.5. Market Size and Forecast, By End User
    • 9.4.12. South Korea Custom Antibody Services Market
      • 9.4.12.1. Market Size and Forecast, By Service
      • 9.4.12.2. Market Size and Forecast, By Type
      • 9.4.12.3. Market Size and Forecast, By Source
      • 9.4.12.4. Market Size and Forecast, By Application
      • 9.4.12.5. Market Size and Forecast, By End User
    • 9.4.13. Rest of Asia-Pacific Custom Antibody Services Market
      • 9.4.13.1. Market Size and Forecast, By Service
      • 9.4.13.2. Market Size and Forecast, By Type
      • 9.4.13.3. Market Size and Forecast, By Source
      • 9.4.13.4. Market Size and Forecast, By Application
      • 9.4.13.5. Market Size and Forecast, By End User
  • 9.5. LAMEA
    • 9.5.1. Key Market Trends and Opportunities
    • 9.5.2. Market Size and Forecast, By Service
    • 9.5.3. Market Size and Forecast, By Type
    • 9.5.4. Market Size and Forecast, By Source
    • 9.5.5. Market Size and Forecast, By Application
    • 9.5.6. Market Size and Forecast, By End User
    • 9.5.7. Market Size and Forecast, By Country
    • 9.5.8. Brazil Custom Antibody Services Market
      • 9.5.8.1. Market Size and Forecast, By Service
      • 9.5.8.2. Market Size and Forecast, By Type
      • 9.5.8.3. Market Size and Forecast, By Source
      • 9.5.8.4. Market Size and Forecast, By Application
      • 9.5.8.5. Market Size and Forecast, By End User
    • 9.5.9. Saudi Arabia Custom Antibody Services Market
      • 9.5.9.1. Market Size and Forecast, By Service
      • 9.5.9.2. Market Size and Forecast, By Type
      • 9.5.9.3. Market Size and Forecast, By Source
      • 9.5.9.4. Market Size and Forecast, By Application
      • 9.5.9.5. Market Size and Forecast, By End User
    • 9.5.10. South Africa Custom Antibody Services Market
      • 9.5.10.1. Market Size and Forecast, By Service
      • 9.5.10.2. Market Size and Forecast, By Type
      • 9.5.10.3. Market Size and Forecast, By Source
      • 9.5.10.4. Market Size and Forecast, By Application
      • 9.5.10.5. Market Size and Forecast, By End User
    • 9.5.11. Rest of LAMEA Custom Antibody Services Market
      • 9.5.11.1. Market Size and Forecast, By Service
      • 9.5.11.2. Market Size and Forecast, By Type
      • 9.5.11.3. Market Size and Forecast, By Source
      • 9.5.11.4. Market Size and Forecast, By Application
      • 9.5.11.5. Market Size and Forecast, By End User

CHAPTER 10: COMPETITIVE LANDSCAPE

  • 10.1. Introduction
  • 10.2. Top Winning Strategies
  • 10.3. Product Mapping of Top 10 Player
  • 10.4. Competitive Dashboard
  • 10.5. Competitive Heatmap
  • 10.6. Top Player Positioning, 2023

CHAPTER 11: COMPANY PROFILES

  • 11.1. Thermo Fisher Scientific Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Key Executives
    • 11.1.3. Company Snapshot
    • 11.1.4. Operating Business Segments
    • 11.1.5. Product Portfolio
    • 11.1.6. Business Performance
    • 11.1.7. Key Strategic Moves and Developments
  • 11.2. Merck KGaA
    • 11.2.1. Company Overview
    • 11.2.2. Key Executives
    • 11.2.3. Company Snapshot
    • 11.2.4. Operating Business Segments
    • 11.2.5. Product Portfolio
    • 11.2.6. Business Performance
    • 11.2.7. Key Strategic Moves and Developments
  • 11.3. Agilent Technologies, Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Key Executives
    • 11.3.3. Company Snapshot
    • 11.3.4. Operating Business Segments
    • 11.3.5. Product Portfolio
    • 11.3.6. Business Performance
    • 11.3.7. Key Strategic Moves and Developments
  • 11.4. Sino Biological, Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Key Executives
    • 11.4.3. Company Snapshot
    • 11.4.4. Operating Business Segments
    • 11.4.5. Product Portfolio
    • 11.4.6. Business Performance
    • 11.4.7. Key Strategic Moves and Developments
  • 11.5. Bio-Rad Laboratories, Inc
    • 11.5.1. Company Overview
    • 11.5.2. Key Executives
    • 11.5.3. Company Snapshot
    • 11.5.4. Operating Business Segments
    • 11.5.5. Product Portfolio
    • 11.5.6. Business Performance
    • 11.5.7. Key Strategic Moves and Developments
  • 11.6. Kaneka Eurogentec S.A.
    • 11.6.1. Company Overview
    • 11.6.2. Key Executives
    • 11.6.3. Company Snapshot
    • 11.6.4. Operating Business Segments
    • 11.6.5. Product Portfolio
    • 11.6.6. Business Performance
    • 11.6.7. Key Strategic Moves and Developments
  • 11.7. YenZym Antibodies, LLC.
    • 11.7.1. Company Overview
    • 11.7.2. Key Executives
    • 11.7.3. Company Snapshot
    • 11.7.4. Operating Business Segments
    • 11.7.5. Product Portfolio
    • 11.7.6. Business Performance
    • 11.7.7. Key Strategic Moves and Developments
  • 11.8. OriGene Technologies, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Key Executives
    • 11.8.3. Company Snapshot
    • 11.8.4. Operating Business Segments
    • 11.8.5. Product Portfolio
    • 11.8.6. Business Performance
    • 11.8.7. Key Strategic Moves and Developments
  • 11.9. Laboratory Corporation of America Holdings.
    • 11.9.1. Company Overview
    • 11.9.2. Key Executives
    • 11.9.3. Company Snapshot
    • 11.9.4. Operating Business Segments
    • 11.9.5. Product Portfolio
    • 11.9.6. Business Performance
    • 11.9.7. Key Strategic Moves and Developments
  • 11.10. GenScript
    • 11.10.1. Company Overview
    • 11.10.2. Key Executives
    • 11.10.3. Company Snapshot
    • 11.10.4. Operating Business Segments
    • 11.10.5. Product Portfolio
    • 11.10.6. Business Performance
    • 11.10.7. Key Strategic Moves and Developments